2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment

For the first time, zinc oxide (ZnO) nanoparticles (NPs) are synthesized by the green combustion method using apple peel extract as a reducing agent. Further, ZnO-Deoxy-d-Glucose (2DG) nanohybrids were synthesized by the sputtering method. These synthesized biomolecule-coated NPs and nanohybrids are...

Full description

Bibliographic Details
Main Authors: Y.S. Vidya, H.C. Manjunatha, S. Manjunatha, K.N. Sridhar, L. Seenappa, R. Munirathnam
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Journal of Science: Advanced Materials and Devices
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468217923000564
_version_ 1797737262816952320
author Y.S. Vidya
H.C. Manjunatha
S. Manjunatha
K.N. Sridhar
L. Seenappa
R. Munirathnam
author_facet Y.S. Vidya
H.C. Manjunatha
S. Manjunatha
K.N. Sridhar
L. Seenappa
R. Munirathnam
author_sort Y.S. Vidya
collection DOAJ
description For the first time, zinc oxide (ZnO) nanoparticles (NPs) are synthesized by the green combustion method using apple peel extract as a reducing agent. Further, ZnO-Deoxy-d-Glucose (2DG) nanohybrids were synthesized by the sputtering method. These synthesized biomolecule-coated NPs and nanohybrids are characterized with different techniques. The Bragg reflections confirm the hexagonal Wurtzite structure for ZnO. A decrease in crystallite size and an increase in energy band gap were observed for ZnO and ZnO-2DG. The tuning of the band gap plays a vital role in cytotoxicity, arbitrated by intracellular reactive oxygen species. The cytotoxic properties, such as the percentage of inhibition and the percentage of the proliferation of ZnO and ZnO-2DG nanohybrid, are examined against the Kidney cancer Vero cell line and also compared with the standard drugs Levofloxacin and Doxorubicin. Compared to ZnO, ZnO-2DG shows excellent cytotoxic properties, even better than the standard drug against the Vero cell line. Thus, the present ZnO-2DG nanohybrid might be used as a nanodrug and go on to replace Levofloxacin and Doxorubicin as standard drugs in kidney cancer cell therapy.
first_indexed 2024-03-12T13:27:07Z
format Article
id doaj.art-12e3349054b54ed9b29d52d1e651902b
institution Directory Open Access Journal
issn 2468-2179
language English
last_indexed 2024-03-12T13:27:07Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Journal of Science: Advanced Materials and Devices
spelling doaj.art-12e3349054b54ed9b29d52d1e651902b2023-08-25T04:24:32ZengElsevierJournal of Science: Advanced Materials and Devices2468-21792023-09-01831005872-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatmentY.S. Vidya0H.C. Manjunatha1S. Manjunatha2K.N. Sridhar3L. Seenappa4R. Munirathnam5Department of Physics, Lal Bahadur Shastri Government First Grade College, RT Nagar, Bangalore, 560032, Karnataka, India; Corresponding author.Department of Physics, Government College for Women, Kolar, 563101, Karnataka, India; Corresponding author.Department of Chemistry, B.M.S College of Engineering, Bengaluru, 560019, Karnataka, IndiaDepartment of Physics, Government First Grade College, Kolar, 563101, Karnataka, IndiaDepartment of Physics, Government College for Women, Kolar, 563101, Karnataka, IndiaDepartment of Physics, Government College for Women, Kolar, 563101, Karnataka, IndiaFor the first time, zinc oxide (ZnO) nanoparticles (NPs) are synthesized by the green combustion method using apple peel extract as a reducing agent. Further, ZnO-Deoxy-d-Glucose (2DG) nanohybrids were synthesized by the sputtering method. These synthesized biomolecule-coated NPs and nanohybrids are characterized with different techniques. The Bragg reflections confirm the hexagonal Wurtzite structure for ZnO. A decrease in crystallite size and an increase in energy band gap were observed for ZnO and ZnO-2DG. The tuning of the band gap plays a vital role in cytotoxicity, arbitrated by intracellular reactive oxygen species. The cytotoxic properties, such as the percentage of inhibition and the percentage of the proliferation of ZnO and ZnO-2DG nanohybrid, are examined against the Kidney cancer Vero cell line and also compared with the standard drugs Levofloxacin and Doxorubicin. Compared to ZnO, ZnO-2DG shows excellent cytotoxic properties, even better than the standard drug against the Vero cell line. Thus, the present ZnO-2DG nanohybrid might be used as a nanodrug and go on to replace Levofloxacin and Doxorubicin as standard drugs in kidney cancer cell therapy.http://www.sciencedirect.com/science/article/pii/S2468217923000564Zinc oxideNanohybridVero cell lineKidney cancer cellCytotoxic
spellingShingle Y.S. Vidya
H.C. Manjunatha
S. Manjunatha
K.N. Sridhar
L. Seenappa
R. Munirathnam
2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
Journal of Science: Advanced Materials and Devices
Zinc oxide
Nanohybrid
Vero cell line
Kidney cancer cell
Cytotoxic
title 2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
title_full 2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
title_fullStr 2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
title_full_unstemmed 2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
title_short 2-Deoxy-d-glucose functionalized zinc oxide nanodrug for kidney cancer treatment
title_sort 2 deoxy d glucose functionalized zinc oxide nanodrug for kidney cancer treatment
topic Zinc oxide
Nanohybrid
Vero cell line
Kidney cancer cell
Cytotoxic
url http://www.sciencedirect.com/science/article/pii/S2468217923000564
work_keys_str_mv AT ysvidya 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment
AT hcmanjunatha 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment
AT smanjunatha 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment
AT knsridhar 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment
AT lseenappa 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment
AT rmunirathnam 2deoxydglucosefunctionalizedzincoxidenanodrugforkidneycancertreatment